Sonus Pharmaceuticals, Inc.
Records under this name other than patents Sonus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Sonus Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,723,303 | Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane Formerly held Term ended Term ended Nov 20, 2025 · From the USPTO record | Term ended | Term ended Nov 20, 2025 | From the USPTO record |
| US 6,982,282 | Emulsion vehicle for poorly soluble drugs Formerly held Term ended Term ended Sep 24, 2018 · From the USPTO record | Term ended | Term ended Sep 24, 2018 | From the USPTO record |
| US 7,030,155 | Emulsion vehicle for poorly soluble drugs Formerly held Lapsed on the fee record Ended Apr 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Apr 18, 2018 | From the USPTO record |
| US 6,458,373 | Emulsion vehicle for poorly soluble drugs Formerly held Term ended Term ended Jan 5, 2018 · From the USPTO record | Term ended | Term ended Jan 5, 2018 | From the USPTO record |
| US 7,268,245 | Multinuclear platinum compounds Lapsed on the fee record Ended Sep 11, 2015 · From the USPTO record | Lapsed on the fee record | Ended Sep 11, 2015 | From the USPTO record |
| US 7,232,919 | Platinum compounds Lapsed on the fee record Ended Jun 19, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2015 | From the USPTO record |
| US 7,223,770 | Tocopherol-modified therapeutic drug compounds Lapsed on the fee record Ended May 29, 2015 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2015 | From the USPTO record |
| US 6,479,540 | Compositions of tocol-soluble therapeutics Lapsed on the fee record Ended Nov 12, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 12, 2014 | From the USPTO record |
| US 7,129,368 | Platinum carboxylate anticancer compounds Lapsed on the fee record Ended Oct 31, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 31, 2014 | From the USPTO record |
| US 7,786,134 | Lipophilic anticancer drug compounds, compositions and related methods Lapsed on the fee record Ended Aug 31, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 31, 2014 | From the USPTO record |